Merck (MRK) Tops Q1 EPS by 5c; Offers FY23 Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $150.08 -1.03%
EPS Growth %: -14.0%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
VIVO, PMCB, PLCE, More
EPS Growth %: -14.0%
Financial Fact:
Sales: 23.64B
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q1 EPS of $1.40, $0.05 better than the analyst estimate of $1.35. Revenue for the quarter came in at $0 versus the consensus estimate of $13.78 billion.
GUIDANCE:
Merck sees FY2023 EPS of $6.88-$7.00, versus the consensus of $6.91. Merck sees FY2023 revenue of $57.7-58.9 billion, versus the consensus of $58.3 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
- C3.ai (AI) Tops Q1 EPS by 5c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
